Myeloablative versus non-myeloablative consolidative chemotherapy for newly diagnosed primary central nervous system lymphoma: Results of induction therapy in CALGB 51101 (Alliance)
   Google Scholar   
Citation:
J Clin Oncol. vol 38 (15_suppl) abst 8042
Meeting Instance:
ASCO 2020
Year:
2020
Type:
Abstract
Sub type:
Poster General
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
No
DataSharing:
No
SDC:
No
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
Lymphoma
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180821, U10CA180882  
Corr. Author:
 
Authors:
                   
Networks:
ADM403, ALLIANCE, CA136, CAPITAL, LAPS-MA036, LAPS-MN026, LAPS-MO011, MCRC, NC002, NY018, UPSTATE   
Study
CALGB-51101
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords: